| dc.contributor.author | Cheah, Keith M | |
| dc.contributor.author | Jun, Joomyung V | |
| dc.contributor.author | Wittrup, K Dane | |
| dc.contributor.author | Raines, Ronald T | |
| dc.date.accessioned | 2026-02-26T22:25:06Z | |
| dc.date.available | 2026-02-26T22:25:06Z | |
| dc.date.issued | 2022-08-29 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/164975 | |
| dc.description.abstract | The carboxyl groups of a protein can be esterified by reaction with a diazo compound, 2-diazo-2-(p-methylphenyl)-N,N-dimethylacetamide. This esterification enables the entry of the protein into the cytosol of a mammalian cell, where the nascent ester groups are hydrolyzed by endogenous esterases. The low aqueous solubility of the ensuing esterified protein is, however, a major practical challenge. Solubility screening revealed that β-cyclodextrin (β-CD) is an optimal solubilizing agent for esterified green fluorescent protein (est-GFP). Its addition can increase the recovery of est-GFP by 10-fold. α-CD, γ-CD, and cucurbit-7-uril are less effective excipients. 1H NMR titration experiments revealed that β-CD encapsulates the hydrophobic tolyl group of ester conjugates with Ka = 321 M–1. Combining l-arginine and sucrose with β-CD enables the nearly quantitative recovery of est-GFP. Thus, the insolubility of esterified proteins can be overcome with excipients. | en_US |
| dc.language.iso | en | |
| dc.publisher | American Chemical Society | en_US |
| dc.relation.isversionof | 10.1021/acs.molpharmaceut.2c00368 | en_US |
| dc.rights | Creative Commons Attribution-Noncommercial-ShareAlike | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | en_US |
| dc.source | PubMed Central | en_US |
| dc.title | Host–Guest Complexation by β-Cyclodextrin Enhances the Solubility of an Esterified Protein | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Keith M. Cheah, Joomyung V. Jun, K. Dane Wittrup, and Ronald T. Raines
Molecular Pharmaceutics 2022 19 (11), 3869-3876. | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Chemical Engineering | en_US |
| dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | en_US |
| dc.relation.journal | Molecular Pharmaceutics | en_US |
| dc.eprint.version | Author's final manuscript | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dc.date.updated | 2026-02-26T21:59:52Z | |
| dspace.orderedauthors | Cheah, KM; Jun, JV; Wittrup, KD; Raines, RT | en_US |
| dspace.date.submission | 2026-02-26T21:59:54Z | |
| mit.journal.volume | 19 | en_US |
| mit.journal.issue | 11 | en_US |
| mit.license | OPEN_ACCESS_POLICY | |
| mit.metadata.status | Authority Work and Publication Information Needed | en_US |